BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6489441)

  • 1. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy.
    Jefferys D; Copolov D; Funder JW
    Eur J Pharmacol; 1984 Aug; 103(3-4):205-10. PubMed ID: 6489441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effect of adrenalectomy: reversal by glucocorticoids or [D-Ala2,Met5]enkephalinamide.
    Jefferys D; Copolov D; Irby D; Funder J
    Eur J Pharmacol; 1983 Aug; 92(1-2):99-103. PubMed ID: 6628539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
    Wong-Dusting HK; Rand MJ
    Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomy.
    Jefferys D; Boublik J; Funder JW
    Eur J Pharmacol; 1985 Jan; 107(3):331-5. PubMed ID: 2984011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone-reversible effects of d-Ala2-Met5-enkephalinamide-induced behavioral activity in rats.
    Harston CT; Spirtes MA; Dunlap WP; Coy DH
    Behav Neural Biol; 1980 Sep; 30(1):1-19. PubMed ID: 7447858
    [No Abstract]   [Full Text] [Related]  

  • 7. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion.
    Wong TM; Chan SH; Tse SY
    Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids, adrenal medullary opioids, and the retention of a behavioral response after stress.
    Jefferys D; Funder JW
    Endocrinology; 1987 Sep; 121(3):1006-9. PubMed ID: 3622371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus.
    Joyce EM; Koob GF; Strecker R; Iversen SD; Bloom FE
    Brain Res; 1981 Sep; 221(2):359-70. PubMed ID: 7025963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative analysis of the shaking behavior induced in rats by beta-endorphin and [D-Ala2, Met5]enkephalinamide.
    Cowan A; Tortella FC
    Life Sci; 1982 Jan; 30(2):171-6. PubMed ID: 6275233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
    Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
    Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.
    Hashimoto K; Suemaru S; Hattori T; Takao T; Inoue H; Sugawara M; Kageyama J; Ota Z
    Endocrinol Jpn; 1986 Dec; 33(6):813-20. PubMed ID: 3034557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D-Ala2-Met5-enkephalinamide microinjections placed into the bed nucleus of the stria terminalis upon affective defense behavior in the cat.
    Brutus M; Zuabi S; Siegel A
    Brain Res; 1988 Nov; 473(1):147-52. PubMed ID: 3208116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalins have a direct positive inotropic effect on cultured cardiac myocytes.
    Laurent S; Marsh JD; Smith TW
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5930-4. PubMed ID: 2994054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
    Katoh A; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1990 May; 253(2):600-7. PubMed ID: 1971017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis.
    Agmo A; de Avila N
    Pharmacol Biochem Behav; 1985 Apr; 22(4):599-603. PubMed ID: 3991768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite central and peripheral control by endogenous opioids of intestinal motility in fed rats.
    Rivière PJ; Liberge M; Murillo-Lopez D; Bueno L
    Br J Pharmacol; 1989 Sep; 98(1):236-42. PubMed ID: 2679957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid peptide regulation of neurons in the bed nucleus of the stria terminalis: a microiontophoretic study.
    Dalsass M; Siegel A
    Brain Res; 1990 Oct; 531(1-2):346-9. PubMed ID: 2289135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.
    Phillips AG; LePiane FG
    Behav Brain Res; 1982 Jun; 5(2):225-9. PubMed ID: 7104089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.